Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Active Release Technique vs. Dynamic Soft Tissue Mobilization for Plantar Pain

29 ottobre 2026 aggiornato da: Nosheen Manzoor, University of Management and Technology Lahore

Comparison of Active Release Technique Versus Dynamic Soft Tissue Mobilization on Pain, Range of Motion, Functional Outcomes and Disability in Subjects With Plantar

Plantar fasciitis is one of the most common causes of heel pain encountered in musculoskeletal and orthopedic physiotherapy practice. It is characterized by degenerative changes at the origin of the plantar fascia on the medial calcaneal tubercle, leading to pain, stiffness, and functional limitations during weight-bearing activities. Patients typically report sharp heel pain that is most severe during the first steps in the morning or after prolonged rest, which significantly affects gait and daily functional activities.Current evidence suggests that plantar fasciitis is not purely an inflammatory condition but rather a degenerative fasciopathy resulting from repetitive microtrauma, abnormal foot biomechanics, prolonged standing, obesity, and tightness of the gastrosoleus complex. These mechanical stressors lead to microtears, collagen degeneration, and thickening of the plantar fascia, ultimately resulting in chronic pain and disability.Objective of this study is to compare the effectiveness of Active Release Technique and Dynamic Soft Tissue Mobilization on pain, function, and disability in patients with plantar fasciitis. All the subjects who will eligible for the criteria will randomly allocated in to Group A(ART) and Group B(DSTM).Taping will be our baseline treatment.. This study will be a randomized controlled trial conducted at Pro Care Physiotherapy Clinic, Ittefaq Hospital, and Iffat Anwar Medical Complex over a period of four months. A total of 62 participants will be recruited using probability convenient sampling and randomly allocated into two groups. Group A will receive Active Release Technique along with baseline taping, while Group B will receive Dynamic Soft Tissue Mobilization along with baseline taping. Both groups will receive three sessions per week for four weeks.Outcome measures will include the Numerical Pain Rating Scale (NPRS) and Foot Function Index (FFI) to assess pain and functional disability. Assessments will be taken at baseline, 2nd week, and 4th week. Data will be analyzed using SPSS version 24, and both intra-group and inter-group comparisons will be performed using appropriate statistical tests.

Panoramica dello studio

Stato

Attivo, non reclutante

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

70

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • University of Management & Technology

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 25 anni a 60 anni (Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

Age 25 to 60 years. Presence of unilateral plantar fasciitis. Participants with positive Windlass test. Symptoms more than 6 weeks of duration diagnosed by orthopaedician. Reported pain with the first step out of the bed in the morning or with the first step after prolonged immobilization and presence of heel pain with prolonged standing on the medial calcaneal tubercle plantar aponeurosis confirmed by palpation. both male and female will be included. Pain intensity of ≥3 on the Visual Analog Scale (VAS) or Numeric Pain Rating Scale (NPRS).

Participants willing to provide informed consent and comply with the treatment protocol.

Exclusion Criteria:

Reported previous history of cancer, peripheral vascular diseases, lower extremity fractures Had a trauma or history of surgery to the foot or ankle. Diabetic neuropathy. People who have undergone steroid therapy, platelet rich plasma therapy in the past 3 months.

Severe foot deformities (e.g., severe pes planus or pes cavus) requiring specialized management.

Open wounds, skin infections, or allergies preventing the application of taping.

Presence of inflammatory or systemic diseases such as Rheumatoid Arthritis, Ankylosing Spondylitis, or Gout.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Active Release Technique (ART)

The patient will sit in a long-sitting position while the therapist assesses muscle and fascial tightness using their hands. The therapist applies specific pressure along the affected tissue from origin to insertion while the muscle is shortened. The patient is then instructed to lengthen the muscle by dorsiflexing the foot. Each session lasts approximately 10 minutes, three times a week for four weeks, along with baseline taping.

The patient will sit in a long-sitting position while the therapist assesses muscle and fascial tightness using their hands. The therapist applies specific pressure along the affected tissue from origin to insertion while the muscle is shortened. The patient is then instructed to lengthen the muscle by dorsiflexing the foot. Each session lasts approximately 10 minutes, three times a week for four weeks, along with baseline taping.

Comparatore attivo: Dynamic Soft Tissue Mobilization

The therapist will perform 10 minutes of deep, forceful soft tissue mobilization on tight and painful areas of the posterior calf muscles, applying pressure across the muscle fibers medially and laterally. The patient will also perform a passive straight leg raise combined with ankle dorsiflexion using a long belt to improve neural mobility.

The therapist will perform 10 minutes of deep, forceful soft tissue mobilization on tight and painful areas of the posterior calf muscles, applying pressure across the muscle fibers medially and laterally. The patient will also perform a passive straight leg raise combined with ankle dorsiflexion using a long belt to improve neural mobility.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pain by Numerical Rating Scale (NPRS)
Lasso di tempo: At baseline and after 6 weeks

Numeric Rating Scale (NPRS) is most frequently used instruments to measure pain. The 11-point numeric with 0 representing No pain, 1- 3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains

(interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs).

At baseline and after 6 weeks
Disability by Foot Function Index (FFI)
Lasso di tempo: At baseline and after 6 weeks

The Foot Function Index (FFI) is a widely used patient-reported outcome measure developed to assess the impact of foot pathology on pain, disability, and activity limitation.The questionnaire consists of 23 items divided into three subscales: Pain (9 items), Disability (9 items), and Activity Limitation (5 items). The questions assess foot pain severity and the extent to which foot problems affect daily functional activities such as walking, standing, climbing stairs, and participation in routine activities.

At baseline and after 6 weeks
Joint Range of Motion by Goniometer
Lasso di tempo: At baseline and after 6 weeks

The patient's knee will be flexed to 30°, with the ankle in the anatomical position. The goniometer axis will be placed near the lateral ankle, with the stationary arm aligned along the fibula and the movable arm along the fifth metatarsal. The examiner will measure both passive and active ankle dorsiflexion using a goniometer. The normal range of ankle dorsiflexion is approximately 15°-20°.

At baseline and after 6 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

29 ottobre 2026

Completamento primario (Stimato)

31 dicembre 2026

Completamento dello studio (Stimato)

31 dicembre 2026

Date di iscrizione allo studio

Primo inviato

29 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

29 ottobre 2026

Primo Inserito (Effettivo)

4 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

4 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

29 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • RE-207-2026

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

The results data collected , de-identified individual participant data will be shared.

Periodo di condivisione IPD

6 months after the publication of the manuscript.

Criteri di accesso alla condivisione IPD

The data can be requested from the corresponding author.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • ICF

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .